Key Points
- Director Jack Lazar sold 7,500 shares on March 5 at an average price of $119.80 for about $898,500, trimming his stake by 7.91% to 87,351 shares valued at roughly $10.46 million.
- Strong quarterly results: the company reported $0.58 EPS (vs. $0.51 expected) and revenue of $270.6 million (vs. $249.5 million), a 91.8% year‑over‑year revenue increase, and set Q1 2026 guidance of $0.530–$0.540 EPS.
- Market view: the stock has a $20.82 billion market cap, recent upside of about 2.6%, and an average analyst rating of "Moderate Buy" with an average target price of $195.89.
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Jack Lazar sold 7,500 shares of the firm's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total value of $898,500.00. Following the sale, the director directly owned 87,351 shares in the company, valued at approximately $10,464,649.80. This trade represents a 7.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Astera Labs Stock Up 2.6%
Shares of ALAB opened at $122.31 on Tuesday. The stock has a market cap of $20.82 billion, a PE ratio of 100.25, a PEG ratio of 2.35 and a beta of 1.75. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The business has a 50-day simple moving average of $151.93 and a two-hundred day simple moving average of $169.65.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts' consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business's revenue for the quarter was up 91.8% on a year-over-year basis. During the same period last year, the firm posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.
Hedge Funds Weigh In On Astera Labs
Several institutional investors have recently made changes to their positions in the stock. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company's stock valued at $25,000 after buying an additional 101 shares during the period. Reflection Asset Management acquired a new position in Astera Labs during the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC raised its stake in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock worth $32,000 after buying an additional 152 shares during the period. Hilltop National Bank boosted its holdings in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company's stock worth $33,000 after acquiring an additional 100 shares in the last quarter. Finally, Aventura Private Wealth LLC acquired a new stake in Astera Labs in the fourth quarter valued at approximately $33,000. Institutional investors and hedge funds own 60.47% of the company's stock.
Analysts Set New Price Targets
ALAB has been the topic of a number of research reports. Jefferies Financial Group reissued a "buy" rating on shares of Astera Labs in a report on Wednesday, December 3rd. Barclays set a $165.00 price target on shares of Astera Labs in a report on Thursday, January 15th. BNP Paribas Exane began coverage on Astera Labs in a report on Thursday, November 20th. They issued an "outperform" rating for the company. Wall Street Zen lowered Astera Labs from a "buy" rating to a "hold" rating in a research report on Tuesday, November 11th. Finally, Loop Capital started coverage on Astera Labs in a report on Thursday, March 5th. They set a "buy" rating and a $250.00 target price on the stock. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $195.89.
View Our Latest Research Report on Astera Labs
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
